PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Aug-2023 Un gran numero di azionisti si unisce al Comitato per ripristinare il valore azionario di Nymox ("The Committee to Restore Nymox Shareholder Valu"), riempiendo di email il sito per esprimere l'insoddisfazione la la leadership di NYMOX Businesswire
09-Aug-2023 Golf aandeelhouders voegt zich bij het comité om de Nymox-aandeelhouderwaarde te herstellen, website overspoeld met e-mails die ontevredenheid spuien over het bewind bij NYMOX Businesswire
09-Aug-2023 Una oleada de accionistas se une al Committee to Restore Nymox Shareholder Value y el sitio web se inunda de correos electrónicos en los que se expresa el descontento con la dirección de Nymox Businesswire
09-Aug-2023 Une vague d’actionnaires rejoint le Committee to Restore Nymox Shareholder Value et inonde le site web d’e-mails exprimant leur mécontentement à l’égard de la direction de Nymox Businesswire
09-Aug-2023 Zahlreiche Aktionäre treten dem Komitee zur Wiederherstellung des Unternehmenswerts von Nymox bei, E-Mails auf Deluge Website bringen Unzufriedenheit mit NYMOX-Führung zum Ausdruck Businesswire
08-Aug-2023 Aldeyra Therapeutics, Inc. (ALDX) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Aldeyra Therapeutics, Inc. Securities Class Action Businesswire
08-Aug-2023 Kodak Reports Second-Quarter 2023 Financial Results Businesswire
08-Aug-2023 Rocket Lab Announces Second Quarter 2023 Financial Results, Issues Guidance For Continued Revenue Growth In Third Quarter 2023 Businesswire
08-Aug-2023 Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update Businesswire
08-Aug-2023 Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress Businesswire
08-Aug-2023 Model N Announces Third Quarter Fiscal Year 2023 Financial Results Businesswire
08-Aug-2023 Personalis Reports Second Quarter 2023 Financial Results Businesswire
08-Aug-2023 Danimer Scientific Invited into Due Diligence and Term Sheet Negotiation Phase for a Federal Financing Bank Loan and DOE Loan Guarantee Businesswire
08-Aug-2023 Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1) Businesswire
08-Aug-2023 Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results Businesswire
08-Aug-2023 Ligand Reports Second Quarter 2023 Financial Results Businesswire
08-Aug-2023 Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress Businesswire
08-Aug-2023 Viridian Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update Businesswire
08-Aug-2023 Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update Businesswire
08-Aug-2023 Establishment Labs Reports Record Second Quarter 2023 Financial Results Businesswire